Skip to content

A systems biology approach to ocular inflammation

A systems biology approach to ocular inflammation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON22439
Enrollment
440
Registered
2014-06-04
Start date
2013-12-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

(non-infectious) ocular inflammation, uveitis, age related macular degeneration, inflammatory corneal disease, idiopathic inflammatory orbital disease

Interventions

Sponsors

University Medical Centre Utrecht
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - 18-95 years of age - diagnosed with non-infectious uveitis (anterior, intermediate, posterior, panuveitis, scleritis) OR - inflammatory corneal disease (keratokonus, Fuchs endothelial corneal dystrophy) OR - idiopathic inflammatory orbital disease OR - age-related macular degeneration

Exclusion criteria

Exclusion criteria: - (acquired) immune deficiencies - inadequate knowledge of Dutch - current use of systemic immunomodulatory agents, biologicals or cyclosporine - IV corticosteroids in last 14 days before inclusion

Design outcomes

Primary

MeasureTime frame
We aim to employ an "omics"-driven systems biology approach on patients with ocular inflammation in order to identify the molecular pathways underlying the pathogenesis of ocular and orbital inflammation and develop clinically usefull markers to predict disease outcome and treatment responses (eg biomarkers). For this we study multiple layers of the immune system (genome, epigenome, proteome, metabolome and cellsubsets).

Secondary

MeasureTime frame
To identify new therapeutical targets for potential use in future clinical studies by evaluation of novel biomarkers in functional models

Contacts

Public ContactJonas Kuiper

Department of Ophthalmology University Medical Centre Utrecht

j.j.w.kuiper@umcutrecht.nl+31 (0)88 7553569

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)